Zygomycosis – black nasal discharge - Causes, Treatment & When to See a Doctor

```html

What is Zygomycosis – Black Nasal Discharge?

Zygomycosis, also called mucormycosis, is a rare but serious fungal infection caused by molds in the order Mucorales. When the infection involves the nasal passages and sinuses it is often called rhino‑cerebral mucormycosis. One of the hallmark visual clues is a thick, dark (often described as “black”) nasal or sinus discharge. The dark color results from tissue necrosis (death) caused by the fungus’s tendency to invade blood vessels, cutting off blood supply to the surrounding tissue.

The disease progresses quickly and can spread from the nasal cavity to the orbit (eye socket) and brain, making early recognition crucial. While it is most frequently seen in people with weakened immune systems, it can also appear in otherwise healthy individuals after severe facial trauma or exposure to contaminated material.

Sources: Mayo Clinic, CDC, NIH, WHO.

Common Causes

Rhino‑cerebral zygomycosis does not have a single cause; rather, it results from a combination of environmental exposure and host factors that diminish the body’s ability to fight the fungus. The most common predisposing conditions include:

• Uncontrolled diabetes mellitus – especially diabetic ketoacidosis, which creates an acidic, glucose‑rich environment ideal for fungal growth.
• Hematologic malignancies (leukemia, lymphoma) and chemotherapy – both suppress immune function.
• Organ or stem‑cell transplantation – immunosuppressive drugs increase susceptibility.
• Prolonged corticosteroid therapy – reduces neutrophil function.
• Iron overload or deferoxamine therapy – the drug acts as a siderophore, delivering iron to the fungus.
• Severe burns, traumatic injuries, or facial surgery – provide a portal of entry for spores.
• Neutropenia – low neutrophil count impairs the body’s primary defense against molds.
• Chronic renal failure & dialysis – associated immune dysfunction.
• Exposure to contaminated soil or decaying organic matter – spores are ubiquitous in the environment.
• Use of contaminated medical supplies – rare but documented outbreaks linked to nasal packing, ventilator circuits, or humidifiers.

Associated Symptoms

Because the fungus invades blood vessels and surrounding tissue, patients often present with a cluster of symptoms that may develop over days:

• Black or dark brown thick nasal discharge (often foul‑smelling).
• Facial pain, tenderness, or swelling, especially around the cheeks, nose, or upper jaw.
• Fever and chills.
• Nasolabial fold or palate necrosis (blackened tissue inside the mouth).
• Partial loss of sensation (numbness) due to nerve involvement.
• Vision changes: double vision, loss of eye movement, or proptosis (bulging eye).
• Headache, especially localized to the sinus region.
• Ear pain or drainage if the infection spreads to the middle ear.
• Altered mental status, seizures, or focal neurological deficits when the brain is involved.

When to See a Doctor

Any of the following situations should prompt immediate medical evaluation:

• Sudden appearance of black or dark nasal discharge, especially with facial pain or swelling.
• Persistent fever (>38°C/100.4°F) lasting more than 24 hours in a high‑risk individual.
• Vision changes, eye pain, or eye swelling.
• Numbness of the face, palate ulceration, or necrotic tissue in the mouth.
• Severe headache that does not improve with over‑the‑counter analgesics.
• Any neurological symptoms (confusion, seizures, weakness).

Because mucormycosis can progress from the sinuses to the brain within 48‑72 hours, earlier evaluation dramatically improves outcomes.

Diagnosis

Diagnosing rhino‑cerebral zygomycosis requires a combination of clinical suspicion and targeted investigations:

1. Detailed History & Physical Examination

• Identify risk factors (diabetes, immunosuppression, recent trauma).
• Inspect the nasal cavity, oral palate, and facial structures for necrotic tissue.
• Perform a thorough neurologic exam.

2. Imaging Studies

• CT scan of the sinuses – shows bony erosion, sinus opacification, and possible orbital involvement.
• MRI with contrast – superior for detecting soft‑tissue invasion, vascular thrombosis, and early brain spread.
• Chest X‑ray or CT if pulmonary involvement is suspected.

3. Laboratory Tests

• Complete blood count (CBC) with differential – may reveal neutropenia.
• Serum glucose and ketone levels – to assess diabetic control.
• Serum iron studies if deferoxamine therapy is used.

4. Microbiologic Confirmation

• Direct microscopy of nasal or sinus tissue (KOH prep) often shows broad, ribbon‑like, non‑septate hyphae.
• Culture on Sabouraud dextrose agar – grows rapidly (24‑48 h) but may be negative in up to 30 % of cases.
• Histopathology (biopsy) – gold standard; demonstrates tissue invasion by characteristic hyphae and necrosis.
• Polymerase chain reaction (PCR) assays are emerging but not yet routine.

5. Endoscopic Evaluation

Functional endoscopic sinus surgery (FESS) allows both diagnostic sampling and therapeutic debridement. The surgeon can visualize the extent of necrosis and obtain tissue for pathology.

Treatment Options

Management requires a coordinated, multidisciplinary approach—usually involving infectious disease specialists, otolaryngologists, ophthalmologists, and neurosurgeons.

1. Antifungal Therapy

• First‑line: Liposomal Amphotericin B – 5–10 mg/kg IV daily. Preferred due to better renal tolerance compared with conventional amphotericin.
• Step‑down therapy: Posaconazole or Isavuconazole (oral or IV) after initial control, especially when long‑term treatment is needed.
• Treatment duration is typically 6–12 weeks, but may extend based on clinical and radiologic response.

2. Surgical Intervention

• Aggressive debridement of necrotic tissue is essential; incomplete removal leads to rapid recurrence.
• Procedures range from limited endoscopic sinus debridement to extensive craniofacial resection, depending on disease spread.
• Repeated surgeries are common until all devitalized tissue is cleared.

3. Adjunctive Measures

• Control of underlying risk factors – strict glucose control, reversal of ketoacidosis, reduction of immunosuppressive meds when possible.
• Hyperbaric oxygen therapy (HBOT) – may improve oxygenation of hypoxic tissue and enhance neutrophil function; evidence is limited but considered in refractory cases.
• Management of iron overload – discontinue deferoxamine, consider chelation with deferasirox.

4. Home & Supportive Care

• Maintain nasal hygiene with saline irrigation (no alcohol‑based sprays).
• Stay hydrated and monitor temperature twice daily.
• Adhere to medication schedules; use a pill organizer or reminder app.
• Arrange for a caregiver or tele‑health check‑ins if you have limited mobility.

Prevention Tips

Because exposure to Mucorales spores is almost inevitable, prevention focuses on minimizing the host’s vulnerability:

• Optimize diabetes management – aim for HbA1c <7 % and avoid ketoacidosis.
• Limit prolonged use of high‑dose corticosteroids; taper when clinically appropriate.
• For transplant or chemotherapy patients, follow strict infection‑control protocols and keep indoor humidity low.
• Avoid handling decaying organic material (compost, rotting fruit) without gloves, especially if immunocompromised.
• Ensure proper sterilization of medical equipment; ask healthcare providers about the sterility of nasal packs or humidifiers.
• Promptly treat any facial trauma or sinus infection to reduce a portal of entry.
• Educate patients and families about early signs—particularly black nasal discharge.

Emergency Warning Signs

Key Take‑aways

Zygomycosis presenting with black nasal discharge is a medical emergency that demands swift recognition, aggressive antifungal therapy, and often extensive surgery. While the infection is rare, individuals with uncontrolled diabetes, hematologic cancers, or heavy immunosuppression are most at risk. Prompt attention to early warning signs—especially dark nasal discharge paired with facial pain or visual changes—can be lifesaving.

References: Mayo Clinic. “Mucormycosis (black fungus)”; CDC. “Fungal Diseases: Mucormycosis”; NIH National Institute of Allergy and Infectious Diseases; WHO “Fungal Disease Guidelines”; Cleveland Clinic. “Mucormycosis: Symptoms, Diagnosis, and Treatment”.

```